toosendanin has been researched along with Metabolic Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, X; Guo, MQ; Li, J; Li, N; Lu, G; Ma, L; Wu, JL; Yan, X; Zhang, Y; Zhuo, Y | 1 |
1 other study(ies) available for toosendanin and Metabolic Diseases
Article | Year |
---|---|
Integrated Proteomics, Biological Functional Assessments, and Metabolomics Reveal Toosendanin-Induced Hepatic Energy Metabolic Disorders.
Topics: Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Drugs, Chinese Herbal; Energy Metabolism; Glycation End Products, Advanced; Hepatocytes; Metabolic Diseases; Metabolomics; Proteomics; Rats; Rats, Sprague-Dawley | 2019 |